Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Genotypic and phenotypic characterization of HIV-1 patients with primary infection.

Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho DD.

Science. 1993 Aug 27;261(5125):1179-81.

PMID:
8356453
2.

HIV. Towards phase III trials for candidate vaccines.

Ada G.

Nature. 1993 Aug 5;364(6437):489-90. No abstract available.

PMID:
8336788
4.

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD.

J Virol. 1994 Jul;68(7):4650-5.

5.

An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.

Stanhope PE, Liu AY, Pavlat W, Pitha PM, Clements ML, Siliciano RF.

J Immunol. 1993 May 15;150(10):4672-86.

PMID:
8097759
7.

HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes.

Cheynier R, Henrichwark S, Hadida F, Pelletier E, Oksenhendler E, Autran B, Wain-Hobson S.

Cell. 1994 Aug 12;78(3):373-87.

PMID:
7914835
9.

The Thai response to the HIV/AIDS epidemic.

Ungphakorn J, Sittitrai W.

AIDS. 1994;8 Suppl 2:S155-63. No abstract available.

PMID:
7857559
11.

HIV vaccines. Back to primary school.

Moore JP.

Nature. 1995 Jul 13;376(6536):115. No abstract available.

PMID:
7603556
12.

The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus.

Klenerman P, Meier UC, Phillips RE, McMichael AJ.

Eur J Immunol. 1995 Jul;25(7):1927-31.

PMID:
7542596
13.

Virus escape from CTL recognition.

Koup RA.

J Exp Med. 1994 Sep 1;180(3):779-82. No abstract available.

14.

The evaluation of limiting dilution assays.

Fazekas de St Groth.

J Immunol Methods. 1982 Mar 12;49(2):R11-23. Review.

PMID:
7040548
15.

Cytotoxic T-cell immunity to influenza.

McMichael AJ, Gotch FM, Noble GR, Beare PA.

N Engl J Med. 1983 Jul 7;309(1):13-7.

PMID:
6602294
17.

HIV-specific cytotoxic T lymphocytes in seropositive individuals.

Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blumberg RS, Kaplan JC, Hirsch MS, Schooley RT.

Nature. 1987 Jul 23-29;328(6128):345-8.

PMID:
3496541
18.

CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity.

Reddehase MJ, Mutter W, Münch K, Bühring HJ, Koszinowski UH.

J Virol. 1987 Oct;61(10):3102-8.

19.
20.

Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations.

Meyerhans A, Cheynier R, Albert J, Seth M, Kwok S, Sninsky J, Morfeldt-Månson L, Asjö B, Wain-Hobson S.

Cell. 1989 Sep 8;58(5):901-10.

PMID:
2550139

Supplemental Content

Support Center